In Retina Today Stela Vujosevic, MD, Department of Biomedical, Surgical and Dental Sciences, University of Milan and Head, Medical Retina Unit, University Eye Clinic, San Giuseppe Hospital, IRCCS MultiMedica, Milan, Italy presents the RetInSight Fluid Monitor as an example of innovation that helps shape the field of medical retina to improve visual outcomes for patients and reduce the burden of care.

In this recent case report, Valentina Sarao, MD, Daniele Veritti, MD and Paolo Lanzetta, MD, of the Department of Medicine-Ophthalmology, University of Udine and Istituto Europeo di Microchirurgia Oculare (www.iemo.eu) in Udine, Italy , conclude that the information provided by the RetInSight Fluid Monitor was helpful in assessing the effectiveness of the intravitreal ranibizumab treatment and in determining whether additional intervention or drug switching was necessary.

Many thanks to Dr. Pierre-Henry Gabrielle of CHU Dijon Bourgogne for presenting his views on the monitoring of nAMD with the RetInSight Fluid Monitor in a fully occupied room at the congress of the Société Française d’Ophtalmologie. Merci!

Thank you to the 2023 Houska Prize Jury for recognising our achievements in the development of OCT-based AI-software for Age-related Macular Degeneration by nominating us in the category Research & Development in SMEs. We are thankful and proud!

It was good to see you at ARVO 2023 in New Orleans, USA. If you missed the presentations about our algorithms for the monitoring of nAMD ad geographic atrophy, you can find the abstracts by clicking on the read more links.

At this year’s EURETINA in Hamburg, Germany, there were several engaging presentations
during the Symposium Session that took place on the Friday, 2nd September on the
important topic of artificial intelligence (AI) tools for fluid monitoring in neovascular agerelated macular degeneration (nAMD).

Regulatory approval of a novel artificial intelligence-based tool that provides precise measurement of retinal fluid may introduce major paradigm changes in the monitoring of patients with neovascular age-related macular degeneration. “It is a precision management tool, a VEGF meter, which is what Philip Rosenfeld was asking for when anti-VEGF therapies started. More precisely, it is … Read more

At EURETINA and ESCRS 2022, Heidelberg Engineering will present a new feature of its growing healthcare IT portfolio. Heidelberg AppWay, a novel gateway solution for secure data exchange, will allow seamless access to ophthalmic ‘apps’ that aid clinical decision making. For the launch of this workflow solution, Heidelberg Engineering has partnered with the companies RetInSight … Read more

First in class AI-based “fluid activity meter” in nAMD obtains CE Mark

RetInSight, a leader in AI-assisted retinal biomarker image analysis, has received its EU Quality Management System certificate according MDR 2017/745 on December 13, 2021.

Heidelberg Engineering GmbH and RetInSight GmbH intend to interface the RetInSight AI-based fluid monitor application with the Heidelberg Engineering product portfolio, using cloud exchange and application marketplace technologies.

Topcon Healthcare of Oakland, NJ, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will partner with RetInSight GmbH, a developer of retina AI solutions based in Vienna, Austria. The two companies aim to develop a seamless interface between RetInSight’s AI-assisted retinal biomarker applications and Topcon’s market-leading¹ OCT devices and cloud-based data management solution, Harmony.